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Abstract
Objectives—This study examined whether place and socio-economic status had differential
effects on the survival of women diagnosed with breast cancer in Ontario during the 1980s and the
1990s.
Methods—The Ontario Cancer Registry provided 29,934 primary malignant breast cancer cases.
Successive historical cohorts (1986–1988 and 1995–1997) were, respectively, followed until 1994
and 2003. Diverse places were compared: the greater metropolitan Toronto area, other cities,
ranging in size from 50,000 to a million people, smaller towns and villages, and rural and remote
areas. Socio-economic data for each woman’s residence at the time of diagnosis were taken from
population censuses.
Results—Very small cities (6%) with populations between 50,000 and 100,000 were the only
places where breast cancer survival had advanced less compared to the province as a whole.
Income gradients began to appear, however, in larger cities. Urban residents in the lowest income
areas were significantly disadvantaged compared to the highest income areas during the 1990s, but
not during the 1980s.
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Conclusion—This historical analysis of breast cancer survival evidenced remarkably equitable
advances across nearly all of Ontario’s diverse places. The most likely explanation for such
substantial equity seems to be Canada’s universally accessible, single-payer, health care system.
Keywords
Breast cancer; survival; socioeconomic factors; cancer care; universal access; Ontario; health
insurance
Health care cost increases have outpaced other social costs in Canada over the past
generation. While conservative advocates have focused on controlling costs, liberals have
tended to focus on benefits, reminding us that a basic tenet of the Canada Health Act –
equitable health care access – ought to be maintained. Notwithstanding the importance of
interests on both sides of this political debate, it is hoped that science would precede
advocacy. Indeed, the observation of health care outcomes across times and places can
provide empirical sentinels for informing policy decisions. Breast cancer survival is one
such sentinel outcome. The most common type of cancer among Canadian women,1 its
prognosis is excellent with access to early diagnosis and best treatments. Consequently,
breast cancer survival seems a good indicator of a health care system’s performance. This
study will describe breast cancer survival advances across diverse places in a Canadian
province over the past generation.
Studies of survival among women with breast cancer in the 1980s observed equity in the
greater metropolitan Toronto (GMT) area.2–5 Studies that extended analyses to the early
1990s observed modest income-breast cancer survival gradients, indicative of lower survival
in lower-income areas across the province of Ontario.6,7 Because such province-wide
studies possibly confounded place and income, one cannot tell to which specific places their
observed income-survival gradients generalize. A recent study of 1989 to 1993 incident
breast cancer in GMT, however, suggested that income-survival gradients had begun to
appear there.8
Little is known about more recent income-breast cancer survival gradients in Ontario or in
any specific places outside of GMT. This study aims to advance such understandings. It will
examine the effects of place, income and year of diagnosis on breast cancer survival.
METHODS
All 29,934 primary invasive breast cancers (ICD-9 174) diagnosed among women 25 or
older in Ontario between 1986–1988 and 1995–1997 were selected. Their source was the
Ontario Cancer Registry (OCR), estimated to ascertain 98% of such cases.9–11 The 1980s
incidence cohort was followed until January of 1994 and the 1990s cohort until January of
2003.
Statistics Canada and Health Canada definitions were used to construct face-valid places:
city of Toronto (population of nearly 2.5 million), remainder of GMT (total population of
nearly 5 million), large cities (500,000 to 1 million), mid-sized cities (250,000 to 499,999),
small cities (100,000 to 249,999), very small cities (50,000 to 99,999), towns and villages
(10,000 to 49,999), rural (less than 10,000 and less than 400 people per km2), remote (100 to
199 km from the nearest of 10 cancer treatment centres), very remote (200 to 299 km) and
extremely remote (300 km or more).12–14 The distance between each patient’s residence and
the nearest cancer treatment centre was calculated with an ArcGIS Euclidean algorithm.15
Toronto served as the baseline for comparisons.
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Breast cancer cases – 1980s and 1990s cohorts – were joined to socio-economic data
collected by the 1986 and 1996 population censuses.16,17 Linkages were based on each
person’s residential postal code at the time of their diagnosis (96% linkage rate).18 Census
tract (CT, typical population 4,000) median annual household income, available for three
quarters of the cases (urban and immediately exurban, 77%), was the preferred income
definition. The construct and predictive validities of CT-based socio-economic measures
have been established in the US and the better predictive validity of CT median household
income versus CT low-income prevalence in Ontario has been suggested.8,19,20 When CTs
were unavailable, census subdivisions (CSD, 23%, typical population 1,500) were used.
This ecological measure was then used to construct relatively low-to high-income areas;
fifths, thirds or halves, depending on sample requirements. When possible, samples were
designed (minimum 350 per group) to detect small 5-year survival changes (70% [baseline]
to 80% [to detect]): power = .85 and α = .05).21
Maximum likelihood logistic regression models were used to estimate the associations of
place, income area and cohort with 5-year survival adjusted for age.22 Hazards models were
not used because neither cohort nor age met the proportionality assumption.23 All-cause
survival was the outcome of interest for a number of reasons. This study is concerned with
overall cancer burden. Cancer-specific survival rates may underestimate mortality because
the underlying causes of many “non-cancer” deaths can be associated with cancer treatment
(or non-treatment).24 Eight of 10 of the dead study participants died as a direct result of their
cancer, and though length of survival is highly accurate in the OCR, the underlying cause of
death is not.9
Ontario’s health care challenges (waiting lists, investigative and treatment equipment or
physician supply shortages) could be distributed differently across its diverse places. This
historical cohort analysis aims to provide place-specific clues about such potential
challenges by describing how the effect of time (survival advances) differed between places
and income areas in Ontario during the mid-1980s to 2003. Previous studies suggested that
the effect of income increased more in GMT than elsewhere. This interaction hypothesis
(cohort effect moderated by place [GMT/elsewhere] and income) will be tested while others
will be explored across other relatively homogeneous places: mid-sized to large cities, very
small to small cities, towns and villages, and rural and remote places.
RESULTS
The main effects of place and income within cohorts as well as the moderation of cohort
effects across place and income strata are displayed in the top half of Table I. Though
statistically significant moderations of cohort effects were observed, in a practical-policy
sense nearly all places and income areas enjoyed rather large breast cancer survival
advances between 1986 and 2003. Only 4 of 16 places or income areas differed significantly
from the overall cohort effect (OR = 1.56, 95% CI 1.48–1.65 [not shown in table]), two
doing better (extremely remote, and highest-income areas) and two worse (very small cities
and second-lowest income area).
Within the 1980s cohort, the odds of breast cancer survival were slightly lower in other large
Ontario cities compared to Toronto – an 11% differential that approached statistical
significance in the 1990s (OR = 0.89, 95% CI 0.78–1.02). Survival in towns, villages, rural
and remote areas was 15% to 20% lower, a statistically and practically significant difference
that was maintained across cohorts. Across the province, in the 1980s there seemed to have
been no effect of income for the vast majority of women with breast cancer. Only those
living in the lowest fifth of income areas differed slightly from those in the highest fifth (OR
= 0.88, 95% CI 0.78–1.00), but this gradient seemed to become steeper and more pervasive
Gorey et al. Page 3
Can J Public Health. Author manuscript; available in PMC 2010 August 12.
PM
C
 C
anada Author M
anuscript
PM
C
 C
anada Author M
anuscript
PM
C
 C
anada Author M
anuscript
over time. In the 1990s, all other income quintiles differed significantly from the highest
one, and the size of the lowest-highest difference had increased (OR = 0.74, 95% CI 0.66–
0.84).
The bottom half of Table I provides support for this study’s hypothesized cohort effect
moderation by place and income. The increased significance of income was observed in
GMT as well as in other urban places, but not in rural and remote places. No income-
survival gradient was observed in GMT during the 1980s, but a significant one had appeared
in the 1990s so that breast cancer survival advances were significantly greater in the highest
fifth of GMT’s income areas (OR = 1.74, 95% CI 1.48–2.03) compared to the lowest (OR =
1.36, 95% CI 1.05–1.75). This pattern was similar in mid-sized to large cities, but not
elsewhere. It should be noted, however, that even in the lowest-income fifths of GMT and
other mid-sized to large cities, the odds of surviving for 5 years increased substantially (36%
to 47%).
DISCUSSION
Very small cities were the only places where breast cancer survival had advanced less
compared to the province as a whole. There was also a persistent effect of living in smaller
places such as towns and villages, and rural and remote areas that were less than 100 km
from urban centres. Their breast cancer survival rates were slightly less than Toronto’s
during the 1980s and 1990s. Also, income-survival gradients had begun to appear in larger
cities with populations of 250,000 or more. Residents in the lowest fifth of income areas of
such cities were significantly disadvantaged relative to residents of the highest fifth during
the 1990s, but not during the 1980s. However, this developing income-survival gradient
seems modest in comparison to that in the US.25,26 Even in the lowest fifth of income areas
of metropolitan areas in Ontario, breast cancer survival had advanced significantly. In fact,
such advancement was similar to that of white women in the highest fifth of income areas in
metropolitan Detroit, Michigan (Gorey and colleagues, unpublished data). This study’s
breast cancer survival outcomes in Ontario were consistent with systematically reviewed
Canada-US studies that accounted for socio-economic factors, all of which favoured
Canada.27,28 Thus, there seems to be a compelling caution against the call to borrow health
care policies from America.
Favourable outcomes in two places –GMT during the 1980s and extremely remote places in
the 1990s – provide hope that health care challenges in Canada can be met. They record the
histories of high-quality cancer care in distinctly different places in Ontario. The complete
absence of a social gradient in such a diverse megalopolis as Toronto is almost certainly
matchless in worldwide public health annals. And the finding of outcome equity in
extremely remote areas stands in stark contrast to the large disadvantages of such places in
the US.29 During the 1990s, the Ontario Breast Cancer Screening program and regional
cancer centres instituted outreach in numerous remote sites.30 Such apparently effective
programs, in areas where there are not large profits to be made, demonstrate that a largely
publicly funded health care system is capable of expeditious action to effectively meet
identified challenges – probably more so than would be more privately funded systems of
care.
This study’s finding of substantially equitable breast cancer survival advances in Ontario is
consistent with research that found little evidence of socio-economic gradients on cancer
screening, stage or treatments in Ontario.31–37 Even delays to cancer care seem not to be
significantly associated with socio-economic factors.38–42 This study was also consistent
with an Ontario study of breast cancer screening that observed a socio-economic gradient in
urban, but not rural places.32 Perhaps a cancer prevention knowledge divide has begun to
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develop in Canada’s increasingly diverse large cities. The challenges may be very different
in smaller cities and still further different in rural areas. Such are questions for future
research.
Research is also needed to advance understandings of ecological measures of SES in
Canada. One issue that needs to be addressed is the possible effect of their size.43–45
Focusing on CSDs and CTs, this study constructed fairly homogeneous SES measures in
terms of their populations (typically ranged from 1,500 to 4,000). However, in terms of their
areas, such measures ranged widely across the province, from less than 1 km2 to more than
1,000 km2. And they differed between urban and rural areas where typical measures were,
respectively, 1.5 km2 and 30 km2. Though their original conceptual definitions were based
on income status, their ultimate construct definitions could be very different.46 Perhaps the
smaller measures in urban areas are better compositional proxies of personal SES, whereas
larger measures in rural areas are better contextual proxies of health care service
endowments. Finally, this study was limited by its inability to accomplish stage-specific
analyses (OCR did not include breast cancer stage during this study’s time frame). Though
previous studies have suggested the probable impotence of lead-time bias,47,48 staged
analyses would not only allow it to be confidently ruled out, but would also advance
understanding about the relative weight of pre- (primary care, screening) and post-diagnostic
treatment factors in Canadian cancer care.
CONCLUSIONS
The vast majority of women with breast cancer in Ontario during the 1980 and 1990s
enjoyed equitable access to the significant advances in breast cancer care that were a
hallmark of that era. The most likely explanation for such substantial outcome equity seems
to be Canada’s single-payer health care system. This study also serves as a sentinel, warning
that equitable access to health care in Canada may have recently begun to erode.
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